Borghini R, Caronna R, Donato G, Picarelli A. GLP-2 analog Teduglutide in active Crohn's disease and short bowel syndrome: Confirmation of anti-inflammatory role and future perspectives. Dig Liver Dis 2020;52:686-7. [PMID: 32340888 DOI: 10.1016/j.dld.2020.03.019][Cited by in Crossref: 2][Article Influence: 1.0][Reference Citation Analysis]
2
Privitera G, Pugliese D, Lopetuso LR, Scaldaferri F, Papa A, Rapaccini GL, Gasbarrini A, Armuzzi A. Orphan patients with inflammatory bowel disease - when we treat beyond evidence. World J Gastroenterol 2021; 27(47): 8047-8057 [DOI: 10.3748/wjg.v27.i47.8047][Reference Citation Analysis]
3
Borghini R, Villanacci V, Oberti A, Caronna R, Trecca A. Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared. Inflamm Bowel Dis 2021:izab171. [PMID: 34255043 DOI: 10.1093/ibd/izab171][Reference Citation Analysis]